According to bulk deal data available with the BSE, Biocon, the promoter of Syngene International, sold a total of 21,789,164 shares, amounting to a 5.4 percent stake, in the company.
Our specially curated package of the most interesting articles to help you stay at the top of your game.
The deal will most likely be at a discount of up to 5 %, CNBC Awaaz has said
These include multiple drug substance and drug product facilities and other support infrastructure at these sites.
The agency in its charge sheet filed on August 18 has alleged that the bribe payment was being paid to Joint Drug Controller S Eswara Reddy after clearance from associate vice president of Biocon Biologics L Praveen Kumar, they said.
The weekly expiry could keep the markets volatile as we have witnessed steady rise in open interest in 18,000 CE strike in the past few days while on the downside 17,800 PE strike has the highest open interest of more than 2,20,000 contracts which could act as immediate support from current levels.
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 362 in its research report dated July 28, 2022.
The company had posted a net profit of Rs 84 crore in the April-June quarter of the previous fiscal.
Kiran Mazumdar-Shaw called on the International Air Transport Association to look into the global ‘lost luggage crisis’ plaguing the aviation industry.
A CBI court has rejected the bail pleas of Joint Drug Controller S Eswara Reddy and four others for allegedly taking a bribe to waive the phase-3 clinical trial of the Insulin Aspart injection of Biocon Biologics
The court will also give its order on an application to test voice samples of all the arrested in a bribery scandal reportedly involving a joint senior executive of Biocon Biologics.
The CBI counsel today requested the special court for voice sampling of all the five accused.
The manufacturing facility will enhance the company's capability to manufacture drug substance of monoclonal antibodies portfolio.
AREREPL was incorporated on April 13, 2021. It is a special purpose vehicle formed for generation and supply of solar power. It will develop a 30 MWac solar power plant at Benkanhal village in Karnataka, Biocon said in a regulatory filing.
Aiming to revolutionise the cancer therapy treatment in India, Immuneel Therapeutics hopes to bring down the cost of CAR-T therapy for patients.
In a statement, Biocon denied all allegations.
A pharmaceutical company in India must have DGCI approval for selling a new prescription drug. Different countries or blocs have separate regulatory agencies tasked with reviewing new drugs and medical devices before companies can sell them.
After a short-term correction, Dr Reddy's Laboratories has formed higher bottom reversal formation. The stock is consistently taking support near the 50 and 20 day SMA (Rs 4,192, Rs 4,227)
On daily charts, IEX has formed long bullish candle which is broadly positive. But at the same time, the stock is consistently taking resistance near 20 days SMA. The medium term texture of the stock is non-directional, perhaps, traders are waiting for the either side breakout.
Kiran Mazumdar-Shaw on Monday slammed the Karnataka government for the “abominable” condition of roads in the state capital.
Kiran Mazumdar-Shaw announced the death of her mother, Yamini Mazumdar, on Twitter.
In her post, Kiran Mazumdar-Shaw shared an example of a rhopalic sentence - and Tharoor spotted an error.
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 420 in its research report dated April 29, 2022.